SCHEPIS, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.594
AS - Asia 7.284
EU - Europa 5.973
SA - Sud America 1.166
AF - Africa 187
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 15
Totale 28.262
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.305
SG - Singapore 2.147
CN - Cina 1.993
GB - Regno Unito 1.638
IT - Italia 1.396
BR - Brasile 884
VN - Vietnam 778
HK - Hong Kong 749
DE - Germania 718
BD - Bangladesh 487
SE - Svezia 482
FI - Finlandia 447
RU - Federazione Russa 307
KR - Corea 250
FR - Francia 231
UA - Ucraina 194
TR - Turchia 169
ID - Indonesia 141
IN - India 139
CA - Canada 130
AR - Argentina 101
BG - Bulgaria 93
MX - Messico 90
NL - Olanda 78
ES - Italia 74
JP - Giappone 67
PL - Polonia 52
ZA - Sudafrica 49
AE - Emirati Arabi Uniti 48
IQ - Iraq 45
BE - Belgio 41
CO - Colombia 41
PK - Pakistan 38
EC - Ecuador 35
AU - Australia 34
LT - Lituania 34
AT - Austria 32
MA - Marocco 32
EG - Egitto 27
CL - Cile 26
VE - Venezuela 24
RO - Romania 22
UZ - Uzbekistan 22
PH - Filippine 21
MY - Malesia 20
SA - Arabia Saudita 19
CZ - Repubblica Ceca 18
KE - Kenya 18
PY - Paraguay 18
PE - Perù 17
DZ - Algeria 15
IE - Irlanda 15
NP - Nepal 15
TH - Thailandia 14
TN - Tunisia 14
IL - Israele 12
SK - Slovacchia (Repubblica Slovacca) 12
AZ - Azerbaigian 11
JM - Giamaica 11
AL - Albania 10
BH - Bahrain 10
CH - Svizzera 10
CR - Costa Rica 10
KZ - Kazakistan 10
UY - Uruguay 10
BO - Bolivia 9
BY - Bielorussia 9
HN - Honduras 9
DO - Repubblica Dominicana 7
GE - Georgia 7
JO - Giordania 7
LB - Libano 7
LV - Lettonia 7
PT - Portogallo 7
SC - Seychelles 7
EU - Europa 6
GR - Grecia 6
GT - Guatemala 6
KG - Kirghizistan 6
PA - Panama 6
RS - Serbia 6
XK - ???statistics.table.value.countryCode.XK??? 6
CY - Cipro 5
HR - Croazia 5
HU - Ungheria 5
IR - Iran 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
QA - Qatar 5
SI - Slovenia 5
AM - Armenia 4
BZ - Belize 4
EE - Estonia 4
KH - Cambogia 4
NO - Norvegia 4
PR - Porto Rico 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
DK - Danimarca 3
Totale 28.197
Salva come PNG Salva come JPEG
Città #
Ashburn 1.421
Santa Clara 1.405
Singapore 1.274
Fairfield 1.227
Southend 972
Woodbridge 726
Hong Kong 725
Hefei 707
Chandler 599
Houston 577
Seattle 494
San Jose 433
London 429
Cambridge 416
Wilmington 416
Helsinki 377
Modena 328
Ann Arbor 327
Nyköping 320
Jacksonville 312
Beijing 274
New York 264
Dearborn 255
Ho Chi Minh City 252
Los Angeles 247
The Dalles 245
Dallas 243
Seoul 235
Council Bluffs 229
Berlin 217
Hanoi 190
Chicago 180
San Diego 122
Milan 113
Lauterbourg 102
Princeton 96
Jakarta 92
Sofia 89
Buffalo 81
Moscow 79
São Paulo 78
Shanghai 77
Izmir 75
Frankfurt am Main 74
Bologna 70
Salt Lake City 63
Munich 62
Rome 61
Eugene 56
Orem 55
Tokyo 54
Redwood City 50
Phoenix 45
Boardman 40
Grafing 39
Yalova 39
Da Nang 38
Kent 38
Atlanta 35
Brooklyn 35
Nuremberg 35
Warsaw 35
Des Moines 34
Elk Grove Village 34
Nanjing 34
Tampa 34
Guangzhou 33
Rio de Janeiro 33
Brussels 31
Columbus 30
Montreal 29
Redondo Beach 29
Jersey City 28
Naples 28
Haiphong 27
Mexico City 27
Toronto 27
Bremen 26
Chennai 24
Turku 24
Johannesburg 23
Vancouver 23
Falls Church 22
Mumbai 22
Brasília 21
Stockholm 21
Boston 20
Florence 20
Melbourne 20
Portsmouth 20
Tashkent 20
Denver 19
Amsterdam 18
Manchester 18
Miano 18
Wuhan 18
Charlotte 17
Paris 17
Baghdad 16
Biên Hòa 16
Totale 19.165
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 705
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 485
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 478
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 451
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 440
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 435
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 424
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 398
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 389
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 375
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 373
A new device for ultrasound-guided peripheral venous access 353
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis 340
JLB: a flexible and effective device in critical patients. Review of clinical cases 337
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis 325
30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice 322
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. 315
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 315
Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases 314
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 311
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 307
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 305
Consensus conference on TIPS management: Techniques, indications, contraindications 302
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 298
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 291
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 290
Obese zebrafish: A small fish for a major human health condition 290
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 287
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 285
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 285
Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons. 283
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 281
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 277
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 276
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells. 275
Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials 270
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 270
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 266
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. 255
Chemoprevention of hepatocellular carcinoma 254
Baveno VII – Renewing consensus in portal hypertension 252
A RANDOMIZED TRIAL OF THE SAFETY AND HEPATIC HEMODYNAMIC EFFECTS OF INTRAVENOUS CONIVAPTAN IN EUVOLEMIC OR HYPERVOLEMIC CIRRHOTIC PATIENTS 251
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 247
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. 245
Natural history of chronic HBV in northern Italy: Morbidity and morality after 30 years 244
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 241
Protection of human endothelial cells from oxidative stress: Role of Ras-ERK1/2 signaling 239
PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS 238
Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects. 235
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives 235
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 234
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 233
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? 232
When and how to treat acute hepatitis C? 230
Reply to: “Relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis” 228
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis 227
The Coiled-Coil Domain Containing 80 (ccdc80) gene regulates gadd45β2 expression in the developing somites of zebrafish as a new player of the hedgehog pathway 224
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 222
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. 222
Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure 222
Thrombophilic genetic risk factors for liver fibrosis: To screen or not to screen? 221
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease 219
Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis 217
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 215
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 214
Paradoxical embolization in TIPS: take a closer look to the heart 213
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 212
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 211
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 202
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 200
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 199
Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis 199
The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions 198
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) 198
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 197
Transjugular intrahepatic portosystemic shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: a real-life, case-control study 194
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 187
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 185
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 184
Pathophysiology of portal hypertension and variceal bleeding 182
Physical activity in liver transplant recipients: a large multicenter study 174
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 174
Akt1/Akt2 inhibition and development of hepatocellular carcinoma 174
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease 170
Transient elastography and ultrasonography: Optimal evaluation of liver fibrosis and cirrhosis in patients with chronic hepatitis B concurrent with nonalcoholic fatty liver disease 170
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 167
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 167
Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS 166
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation 162
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 161
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome 161
Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex 159
Baveno IV Consensus Statements: Predictive Models in Portal Hypertension 158
Meta-analysis of Transarterial Embolization in Patients with Unresectable Hepatocellular Carcinoma: Dr Camma and colleagues respond 156
Monitoring Treatment of Cirrhosis and Portal Hypertension 154
The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment 153
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 153
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension 153
Reply to: “It takes two “eyes” to see in depth” 151
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974, (S0168827821022996), (10.1016/j.jhep.2021.12.022)] 150
Totale 25.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 0 0 104
2021/20221.883 132 156 157 66 76 111 132 158 213 148 321 213
2022/20231.743 216 209 140 164 155 260 21 177 183 29 126 63
2023/20241.159 50 63 78 118 183 91 152 113 66 21 88 136
2024/20255.274 137 64 66 339 991 747 347 392 768 306 524 593
2025/202611.534 764 573 1.076 1.204 1.264 924 1.226 576 1.047 1.177 840 863
Totale 28.513